scPharmaceuticals Reports Second-Quarter Loss
scPharmaceuticals, Inc. (SCPH) announced a second-quarter loss of $0.34 per share, slightly worse than the Zacks Consensus Estimate of $0.30. This marks an improvement compared to a $0.44 per share loss in the same period last year. The reported figures are adjusted for non-recurring items.
Earnings Performance and Estimates
The earnings results represent a negative surprise of 13.33%. In the previous quarter, the company was expected to report a loss of $0.27 per share but posted a larger loss of $0.34, resulting in a surprise of nearly 26%. Over the past four quarters, scPharmaceuticals has exceeded analyst estimates only once.
Revenue Figures
For the quarter ending June 2025, the company generated revenues of $16.04 million, missing the Zacks Consensus Estimate by 2.19%. Revenue compared favorably to $8.05 million in the same period last year. Over the last four quarters, the company has surpassed revenue estimates just once.
Stock Movement and Outlook
The stock’s short-term movement following these results will largely depend on management’s commentary during the earnings call and...